Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,818.00    -10.00 (-0.35%)
Bid:
2,816.00
Ask:
2,818.00
Spread: 2.00 (0.071%)
Market Cap: £6.70b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Interim Management Statement

5 May 2022 07:00

RNS Number : 3704K
IMI PLC
05 May 2022
 

5 May 2022

Accelerating growth and strategic execution

Group margin target increased to 20%

IMI, the specialist engineering company, issues the following Interim Management Statement which covers results for the first quarter from 1 January to 31 March 2022.

Strong first quarter performance

IMI has delivered another strong performance with first quarter Group revenue growth of 9% compared to the same period last year and 5% higher organically. First quarter margins also slightly improved.

Our teams continue to remain focused on our accelerated growth strategy through increasing customer intimacy, market-led innovation and reducing complexity. These actions have allowed us to generate strong growth in the order book and revenues as well as improving margins, helping to mitigate the ongoing supply chain and inflationary pressures as well as Russian sanctions currently impacting global markets.

Good momentum in our Growth Hub and Sprint Teams continue to drive cultural changes through the business. We remain on track to deliver £40m of orders from these projects in 2022.

IMI Precision's revenue growth was 16% in the first quarter, including a strong performance from Adaptas, our recent acquisition in the attractive Life Sciences sector. Organic revenue growth was 7% versus the same period in 2021, led by Industrial Automation which grew 16%. Precision Fluid OEM organic revenue was in line with the prior year despite an additional £8m contribution from ventilator surge sales in the comparator. Transportation revenue was in line with the prior year despite the ongoing supply chain disruptions impacting the sector.

IMI Critical's order book at the end of March was broadly flat compared to a year ago on a like for like basis, now that we have removed the orders affected by our decision to exit the Russian market. IMI Critical organic order intake in the first three months of 2022 was down 4% versus the same period in 2021 due largely to timing of New Construction orders. Aftermarket orders increased 5% in the period with good spare parts growth in LNG and Gas Power. IMI Critical organic revenue in the three months to the end of March was flat compared to the first quarter of 2021.

IMI Hydronic revenues in the first quarter were 7% higher on an organic basis, when compared to last year. There continues to be strong demand for our energy saving solutions.

Group margin target increased to 20%

Following accelerated progress of our unifying purpose-led strategy [Breakthrough Engineering for a better world], our continued strong trading performance and further opportunities identified for sustained profitable growth, we are pleased to again increase our margin target for the Group to 20% through the cycle.

Our footprint optimisation programme continues to reduce complexity and deliver sustainable margin improvement. This restructuring programme will be expanded by £35m of one-off costs to support the delivery of faster growth and our increased margin target.

Divestment of Russia subsidiary

IMI strongly opposes the invasion of Ukraine. We are deeply concerned for its people and are supporting humanitarian efforts to provide aid for the unfolding refugee crisis.

IMI fully supports all sanctions, and on 4 March 2022 announced its decision to end all new business in and international deliveries to Russia. IMI today announces that it is in the process of divesting its Russian subsidiary to local management, which it expects to complete within the next weeks.

Russia accounted for 2% of Group revenue in 2021 and represented less than 1% of revenue for IMI Precision, 4% for IMI Critical and 2% for IMI Hydronic.

Exchange rates

If exchange rates as at 15 April 2022 of US$1.31 and €1.21 were projected for the full year and applied to our 2021 results, it is estimated that there would be minimal impact to both revenue and operating profit.

Outlook

Based on current market conditions, we continue to expect that 2022 full year adjusted EPS will exceed 100p.

IMI Precision and IMI Hydronic organic revenues are expected to be higher, with margins higher in IMI Precision and slightly higher in IMI Hydronic, consistent with our preliminary results announcement. IMI Critical revenue and operating margin are both expected to be in line with last year, despite the 4% revenue impact from the exit of Russia.

Interim results

 

IMI will issue its interim results announcement in respect of the six months ending 30 June 2022 on 29 July 2022.

 

Enquiries

Luke Grant

IMI

Tel: +44 (0)7866 148 374

Stephen Malthouse

Headland PR

Tel: +44 (0)7734 956 201

A conference call for analysts and investors will be held at 08:00 BST today to discuss this statement. To access the call, please register using the link:

https://www.incommglobalevents.com/registration/client/10691/imi-plc-interim-management-statement-/

Notes

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, sustainably, cleanly, efficiently and cost effectively. IMI employs around 10,000 people, has manufacturing facilities in 19 countries and operates a global service network. The Company is listed on the London Stock Exchange and is a constituent of the FTSE4Good Index. Further information is available at www.imiplc.com.

 

References to adjusted figures reflect figures as reported to management and do not include the impact of adjusting items. References to organic changes are on a constant currency basis and exclude disposals and acquisitions.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZLFBLELZBBV
Date   Source Headline
1st May 201511:19 amRNSTotal Voting Rights
17th Apr 20153:13 pmRNSDirector/PDMR Shareholding
15th Apr 201512:18 pmRNSDirector/PDMR Shareholding
1st Apr 20159:57 amRNSTotal Voting Rights
26th Mar 20153:49 pmRNSAnnual Financial Report
25th Mar 20153:22 pmRNSDirector/PDMR Shareholding
19th Mar 20152:47 pmRNSDirector/PDMR Shareholding
18th Mar 20157:00 amRNSChairman Appointment
11th Mar 20151:37 pmRNSDirector/PDMR Shareholding
9th Mar 201511:02 amRNSAppointment of Divisional Managing Director
6th Mar 20159:39 amRNSDirector Declaration
3rd Mar 20152:22 pmRNSDirector Declaration
2nd Mar 201511:25 amRNSTotal Voting Rights
27th Feb 20157:00 amRNSFinal Results
11th Feb 20152:19 pmRNSDirector/PDMR Shareholding
2nd Feb 201510:26 amRNSTotal Voting Rights
22nd Jan 20154:39 pmRNSHolding(s) in Company
14th Jan 20153:10 pmRNSDirector/PDMR Shareholding
6th Jan 201511:07 amRNSBlocklisting Interim Review
2nd Jan 20153:37 pmRNSCompletion of Bopp & Reuther acquisition
2nd Jan 201512:03 pmRNSTotal Voting Rights
17th Dec 20147:06 amRNSChairman announcement
10th Dec 20143:00 pmRNSDirector/PDMR Shareholding
1st Dec 201411:13 amRNSTotal Voting Rights
27th Nov 20144:10 pmRNSHolding(s) in Company
14th Nov 20147:00 amRNSAcquisition announcement
14th Nov 20147:00 amRNSInterim Management Statement
12th Nov 20142:00 pmRNSDirector/PDMR Shareholding
3rd Nov 201410:02 amRNSTotal Voting Rights
15th Oct 201412:39 pmRNSDirector/PDMR Shareholding
6th Oct 20144:52 pmRNSHolding(s) in Company
6th Oct 20141:00 pmRNSSale of non-core businesses
1st Oct 201410:31 amRNSDirectorate Change
1st Oct 20149:50 amRNSTotal Voting Rights
23rd Sep 20143:15 pmRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSFinance Director Succession
22nd Sep 20144:34 pmRNSDirector/PDMR Shareholding
10th Sep 20143:41 pmRNSDirector/PDMR Shareholding
1st Sep 201412:45 pmRNSTotal Voting Rights
13th Aug 20143:34 pmRNSDirector/PDMR Shareholding
4th Aug 20143:58 pmRNSDirector/PDMR Shareholding
1st Aug 201410:13 amRNSTotal Voting Rights
1st Aug 20147:00 amRNSHalf Yearly Report
9th Jul 20142:07 pmRNSDirector/PDMR Shareholding
2nd Jul 20141:58 pmRNSBlocklisting Interim Review
1st Jul 201410:46 amRNSTotal Voting Rights
17th Jun 20144:35 pmRNSHolding(s) in Company
11th Jun 20141:41 pmRNSDirector/PDMR Shareholding
11th Jun 20141:33 pmRNSDirector Declaration
2nd Jun 201411:09 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.